 NEW YORK, March 11, 2021 GLOBE NEWSWIRE -- SELLAS Life Sciences Group, Inc. Nasdaq: SLS SELLAS or the Company, a late-stage clinical biopharmaceutical company focused on developing novel cancer immunotherapies for a broad range of indications, today announced that Angelos Stergiou, MD, ScD. h.c., President and Chief Executive Officer of SELLAS, will participate in the Emerging Growth Virtual Conference hosted by M Vest LLC and Maxim Group, LLC on Wednesday, March 17, 2021. 